Ironwood Pharmaceuticals | IRWD - Beneficio Operativo

Precio De Mercado
3.50
Cambio Diario
-0.12 -3.31%
Mensual
-27.69%
Anual
133.33%
Q1 Expectativa
3.32




Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Ardelyx USD 4.67M 19.07M 2025-09
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Exact Sciences USD -25M 22.85M 2025-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Lexicon Pharmaceuticals USD -55.35M 10.02M 2024-06
MacroGenics USD 18.64M 55.4M 2025-09
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Pacira USD 3.19M 9.96M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12